CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities attributable to continuing operations:
Net earnings	$ 651,472	$ 359,919	$ 276,554
Add back: loss (earnings) from discontinued operations, net of tax	0	2,211	(509)
Net earnings from continuing operations	651,472	362,130	276,045
Adjustments to reconcile net earnings from continuing operations to net cash provided by operating activities attributable to continuing operations:
Stock-based compensation expense	232,099	203,880	146,816
Depreciation	61,807	43,594	41,402
Impairments and amortization of intangibles	47,731	366,257	28,559
Deferred income taxes	26,612	(29,953)	(57,969)
Other adjustments, net	9,932	6,998	27,690
Changes in assets and liabilities
Accounts receivable	(107,412)	(6,669)	(34,021)
Other assets	25,055	59,584	1,743
Accounts payable and other liabilities	(5,961)	(472,610)	458,757
Income taxes payable and receivable	(3,337)	(1,054)	(2,854)
Deferred revenue	(41,207)	(6,469)	26,331
Net cash provided by operating activities attributable to continuing operations	896,791	525,688	912,499
Cash flows from investing activities attributable to continuing operations:
Cash used in business combinations, net of cash acquired	(11,567)	(25,681)	(859,905)
Capital expenditures	(67,412)	(49,125)	(79,971)
Other, net	2,398	3,104	51
Net cash used in investing activities attributable to continuing operations	(76,581)	(71,702)	(939,825)
Cash flows from financing activities attributable to continuing operations:
Proceeds from Senior Notes offerings	0	0	500,000
Payments to settle exchangeable notes	0	(176,310)	(630,658)
Proceeds from the settlement of exchangeable note hedges	0	75,864	1,089,592
Payments to settle warrants related to exchangeable notes	0	(7,482)	(882,187)
Debt issuance costs	0	0	(7,124)
Proceeds from issuance of common stock pursuant to stock-based awards	19,916	20,485	58,424
Withholding taxes paid on behalf of employees on net settled stock-based awards	(5,933)	(109,256)	(15,726)
Purchase of treasury stock	(546,198)	(482,049)	0
Purchase of noncontrolling interests	(1,872)	(10,554)	(1,473)
Other, net	19	129	258
Net cash (used in) provided by financing activities attributable to continuing operations	(534,068)	(689,173)	111,106
Total cash provided by (used in) continuing operations	286,142	(235,187)	83,780
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	3,782	(7,809)	(7,570)
Net increase (decrease) in cash, cash equivalents, and restricted cash	289,924	(242,996)	76,210
Cash, cash equivalents, and restricted cash at beginning of period	572,516	815,512	739,302
Cash, cash equivalents, and restricted cash at end of period	$ 862,440	$ 572,516	$ 815,512